Navigation Links
International Drug & Explosives Detection Company IDenta Corp. Article to be Published by Zillion International
Date:12/11/2012

JERUSALEM, Dec. 11, 2012 /PRNewswire/ -- IDenta Corp. (OTC Pink: IDTA) CEO Yaacov Shoham today announced that Zillion International - www.zillion.nl - will publish in an article describing in much detail IDenta Corp. and its products.

The article was written by Ellen Groniger

Senior Business Editor
ZILLION Media BV

The article can be seen at the following link:
http://www.yousendit.com/download/WUJZY051UzdEa1ZqQTlVag

IDenta's entire product line may be found at www.Identa-corp.com, www.drugsdetector.com and www.Identa.biz

ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.drugsdetector.com www.identa.biz. www.identa-corp.com

Contact:
Yaacov Shoham CEO
IDenta Corp.
Tel: +972-52-6554487
http://www.identa.biz
fpi@drugsdetector.com  


'/>"/>
SOURCE IDenta Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Hogging the spotlight: South Farms pig gets international attention
2. University of Chicagos Graeme Bell receives international diabetes prize
3. An international competition reaffirms the potential of bioinformatics in the diagnosis of disease
4. Major international push to maximize bioscience research to help worlds poorest farmers
5. International team discovers likely basis of birth defect causing premature skull closure in infants
6. UH Case Medical Center leads international study
7. Novetta Solutions Acquires International Biometric Group, LLC
8. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
9. Maya Angelou Center Brings International Women’s Health Summit to Winston-Salem, NC
10. UA engineering professor Shane Snyder to speak in Korea on international water quality
11. Jeff Crandall Honored With SAE International Arnold W. Siegel International Transportation Safety Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric ... Group (CEG) to market and sell its complete line of biometric readers and ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales ...
(Date:5/28/2020)... Del. (PRWEB) , ... May ... ... Biosciences (DuPont) has announced a new enzyme solution for adjunct liquefaction: AMYLEX® ... alike including the ability to expand into new segments with locally-sourced raw ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing ... engagers and TCR-based therapeutics, has implemented Genedata Biologics ® within their ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
(Date:7/1/2020)... GREEN, Ohio (PRWEB) , ... June 29, 2020 ... ... that offers access to competitively procured purchasing contracts to its membership, recently named ... to provide TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
(Date:6/23/2020)... ... 22, 2020 , ... Regen Suppliers, the one stop shop ... three, get the fourth unit free with no limit on the amniotic derived ... exosomes, have been a game changer for regenerative therapies. The products are manufactured ...
Breaking Biology Technology: